banner

A new generation of Genetically Modified (GM) vaccines: How to overcome the hurdles from bench to practice?

To overcome the limitations of traditional vaccines, the development and use of novel types of vaccines, especially GM based vaccines, are being considered more frequently.

Although GM-based vaccines are endowed with unique and beneficial qualities, major regulatory -, safety - and other aspects need clarification.

 

  • What are the Belgian regulatory guidelines for the development of these novel types of vaccines? Is there a difference with other national regulatory frameworks in European countries?
  • What are the challenges encountered in the pre-clinical and clinical field?
  • How can we guarantee the safety and effectiveness of GM vaccines?
  • Is there an environmental risk associated with the use of GM vaccines?

 

Join this symposium and learn more about these current and interesting topics. A panel of experts will be happy to answer your questions and fuel the discussion.

 

Please find all information on the official website.

 

Event Details

Date:

Tuesday, March 19, 2019 (12:30 h - 17:30 h)

Location:

FOD-WASO – Ernest Blerotstraat 1, 1070 Brussels
(located on the opposite of Pullman Hotel or exit 'Hortaplein' of the railway station Brussels South/Midi)

Price:

Flanders Vaccine members: 40 EUR
non-Flanders Vaccine members: 80 EUR

(prices VAT excluded)

Organiser(s):


This symposium is organised in collaboration with the Federal Agency of Medicines and Health Products (FAMHP).

2019-03-19 12:30:00 2019-03-19 17:30:00 Europe/Brussels A new generation of Genetically Modified (GM) vaccines: How to overcome the hurdles from bench to practice? FOD-WASO – Ernest Blerotstraat 1, 1070 Brussels(located on the opposite of Pullman Hotel or exit 'Hortaplein' of the railway station Brussels South/Midi) <p><img src="/media/3674/logo-fv-2.jpg?width=157&amp;height=67" alt="" width="157" height="67" data-id="10687"></p> <p><br>This symposium is organised in collaboration with the Federal Agency of Medicines and Health Products (FAMHP).<br><br><img style="width: 121px; height: 50px;" src="/media/2555/fagg.jpg?width=121&amp;height=50" alt="" data-id="5364"></p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Event Coordinator

Alternate Text

Lissa Van Hecke

Event Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?